-

Thermo Fisher Scientific Introduces Mass Spectrometers to Simplify Trace Elemental Analysis and Enhance Productivity

Thermo Scientific™ iCAP™ MX Series ICP-MS platform balances sensitivity and efficiency to deliver accurate and precise analysis of high matrix samples

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. today launched the Thermo Scientific iCAP MX Series ICP-MS to simplify trace element analysis with inductively coupled plasma mass spectrometry (ICP-MS). The launch includes a new single quadrupole Thermo Scientific iCAP MSX ICP-MS and triple quadrupole Thermo Scientific iCAP MTX ICP-MS designed for environmental, food, industrial and research labs to analyze routine and challenging trace elements to detect and mitigate harmful substances.

Laboratories that face challenges in analyzing trace elements in complex and diverse matrix samples require sensitive and flexible instruments to deliver consistent results that support analytical research and quality testing. The single quadrupole iCAP MSX ICP-MS delivers a high level of analytical performance without the usual compromise between matrix load and sensitivity, enabling users in applied analytical labs to consistently analyze various elemental samples. Building on this performance, the triple quadrupole iCAP MTX ICP-MS offers interference-free analysis for heightened confidence when analyzing more complex samples.

From environmental testing to food safety, the MSX ICP-MS analyzes a range of samples to meet regulatory and turnaround requirements. Environmental testing labs gain the ability to detect contaminants like lead or mercury to prevent harmful human exposure in drinking water or other environmental samples. Food safety labs achieve fast and accurate analysis of toxic and nutritional elements to ensure food products are safe for consumption and that food labeling requirements are met throughout production. Additionally, labs supporting the high-tech industry can use either instrument in the iCAP MX Series ICP-MS to support production sites and accelerate research discoveries.

“The iCAP MX Series ICP-MS provides simplicity and detection capability without the tradeoff on performance, ultimately maximizing end-to-end productivity to achieve reliable results the first time and increase throughput,” said Alexander Grunewald, vice president and general manager of Applied Analytical Technologies at Thermo Fisher Scientific. “By supporting accurate and reliable trace element analysis across environmental, food safety and industrial markets, our instruments help customers in their quest to make the world healthier, cleaner and safer by removing harmful and toxic substances from our everyday lives.”

Routine maintenance and the associated re-turning of the instrument also can slow productivity in the lab, especially for labs handling heavy matrices. The iCAP MX Series ICP-MS platform combines minimal interference with the flexible matric capabilities of argon gas dilution to ensure the right-first-time analyses of samples. The argon gas dilution features an integrated new cone design and advanced tuning techniques that extend the period between user maintenance from multiple times per week to weekly or less to minimize downtime and improve efficiency.

For more information about how the iCAP MX Series ICP-MS platform will advance critical research and industrial applications that protect environmental and public health, including technical specifications and applications, please visit thermofisher.com/icp-ms.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Contacts

Media Contact Information:
Amir Modirzadeh
amir.modirzadeh@thermofisher.com

Thermo Fisher

NYSE:TMO
Details
Headquarters: Waltham, Massachusetts
CEO: Marc N. Casper
Employees: 100,000
Organization: PUB
Revenues: $40 Billion (2021)

Release Versions

Contacts

Media Contact Information:
Amir Modirzadeh
amir.modirzadeh@thermofisher.com

More News From Thermo Fisher

Thermo Fisher Scientific Deepens Investment in Asia’s Biopharma Ecosystem with Expansion of Bioprocess Design Centers

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced an expansion of its bioprocessing capabilities across Asia, reinforcing its commitment to supporting the region’s rapidly growing biopharmaceutical industry. The company is introducing a new Bioprocess Design Center in Hyderabad, India, and has expanded its existing Bioprocess Design Centers in Incheon, Korea and Singapore, further strengthening a strategic regional network desig...

Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”) announced today that it has priced an offering of €2.1 billion aggregate principal amount (the “Offering”) of the following euro-denominated notes, which will be issued by Thermo Fisher Scientific (Finance I) B.V., its indirect, wholly-owned finance subsidiary: €1,000,000,000 aggregate principal amount of its floating rate senior notes due 2027 (the “floating rate notes”) at the issue price of 100.000%...

Thermo Fisher Scientific’s Oncomine Dx Target Test Receives FDA Approval as a Companion Diagnostic to Identify Patients Eligible for Newest Targeted Therapy for Non-Small Cell Lung Cancer

CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, has received approval from the U.S. Food and Drug Administration (FDA) for its Ion Torrent™ Oncomine™ Dx Target Test as a companion diagnostic (CDx) to identify patients who may be eligible for treatment with HYRNUO™ (sevabertinib), a new HER2-directed therapy developed and commercialized by Bayer. The test enables clinicians and pathologists to identify non-small cell lung cancer (NSCLC) tumors wi...
Back to Newsroom